The price of a drug should be based on its therapeutic benefits – not just what the market will bear
'Orphan drugs' with high price points are being tested as treatments for COVID-19. There's a better way to spur low-cost innovation for new drugs.
Jan. 13, 2021 • ~9 min
covid-19 rheumatoid-arthritis remdesivir pharmaceutical-industry drug-development innovation-and-invention process-of-innovation gilead
The top scientific breakthrough for 2020 was understanding SARS-CoV-2 and how it causes COVID-19 – and then developing multiple vaccines
The development of multiple vaccines against the virus that causes COVID-19 has been hailed as the breakthrough of 2020. But there were many more supporting discoveries that made this possible.
Dec. 17, 2020 • ~11 min
innovation genome covid-19 immune-system pandemic vaccines sars-cov-2 remdesivir drug-development monoclonal-antibodies astrazeneca pfizerbiontech-vaccine moderna-vaccine pfizer-vaccine
Monoclonal antibodies are synthetic molecules manufactured in the lab. But do we need them if a vaccine is on its way?
Nov. 16, 2020 • ~9 min
covid-19 pandemic sars-cov-2 remdesivir viruses antibody steroids monoclonal-antibodies convalescent-plasma dexamethasone
Death rates for hospitalized COVID-19 patients fell from 25.6% in March to 7.6% in August, according to a new study on three hospitals in New York. A study in the U.K. found similar results.
Nov. 3, 2020 • ~6 min
covid-19 treatment remdesivir united-kingdom recovery new-york-city death-rate survival hospital-care dexamethasone coroanvirus
The global pandemic has fueled illicit online sales of COVID-19 commodities, some of which are dangerous or illegal. Researchers are assessing the size and reach of this underground market.
Aug. 19, 2020 • ~7 min
covid-19 coronavirus cybersecurity cybercrime pandemic ppe personal-protective-equipment remdesivir hand-sanitizer hydroxychloroquine fraud unemployment darknet dark-web face-mask
Ending the pandemic will take global access to COVID-19 treatment and vaccines – which means putting ethics before profits
The high cost of pharmaceuticals often means only the richest patients get lifesaving medicines. As coronavirus drugs emerge, it will require hard, creative work to ensure they're available to all.
July 16, 2020 • ~9 min
covid-19 coronavirus global-health ethics inequality tuberculosis prescription-drug-prices remdesivir covid-19-vaccine religion-and-society bioethics access-to-medicines drug-prices essential-medicines polio-vaccination ethical-dilemma
During the last six months, news reports have mentioned dozens of drugs that may be effective against the new coronavirus. Here we lay out the evidence and reveal which ones are proven to work. Or not.
July 1, 2020 • ~7 min
covid-19 coronavirus pandemic sars-cov-2 remdesivir severe-acute-respiratory-syndrome-sars mers-cov hydroxychloroquine chloroquine ace2 treatments cytokine-storm steroids ace-inhibitors
A simple head-to-head trial would resolve this conflict once and for all.
May 11, 2020 • ~7 min
covid-19 coronavirus remdesivir anthony-fauci hydroxychloroquine clinical-trials
Gilead's drug Remdesivir showed preliminary positive results in clinical trials. But what is this drug and how, exactly, does it work?
May 6, 2020 • ~10 min
epidemiology covid-19 pandemic sars-cov-2 remdesivir viruses replication
Vaccines for other diseases are being examined for their protective effects against coronavirus.
April 21, 2020 • ~5 min
covid-19 coronavirus vaccines remdesivir